Growth Metrics

Tandem Diabetes Care (TNDM) Cash from Operations (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12.92%
Dec 31, 2025 18.45%
Sep 30, 2025 187.03%
Jun 30, 2025 48.05%
Mar 31, 2025 -270.55%
Dec 31, 2024 -59.98%
Sep 30, 2024 607.66%
Jun 30, 2024 34.03%
Mar 31, 2024 -10.81%
Dec 31, 2023 -13,220.00%
Sep 30, 2023 100.87%
Jun 30, 2023 65.50%
Mar 31, 2023 -414.88%
Dec 31, 2022 -75.69%
Sep 30, 2022 246.95%
Jun 30, 2022 -49.99%
Mar 31, 2022 -29.72%
Dec 31, 2021 -42.49%
Sep 30, 2021 18.17%
Jun 30, 2021 0.73%
Mar 31, 2021 88.26%
Dec 31, 2020 4.62%
Sep 30, 2020 -6.03%
Jun 30, 2020 175.12%
Mar 31, 2020 -206.11%
Dec 31, 2019 -15.53%
Sep 30, 2019 545.15%
Jun 30, 2019 186.52%
Mar 31, 2019 -129.18%
Dec 31, 2018 508.82%
Sep 30, 2018 48.58%
Jun 30, 2018 45.22%
Mar 31, 2018 -5.42%
Dec 31, 2017 38.79%
Sep 30, 2017 -29.68%
Jun 30, 2017 29.54%
Mar 31, 2017 -53.23%
Dec 31, 2016 25.18%
Sep 30, 2016 -34.55%
Jun 30, 2016 15.38%
Mar 31, 2016 -55.62%
Dec 31, 2015 28.54%
Sep 30, 2015 23.56%
Jun 30, 2015 -21.63%
Mar 31, 2015 -13.92%
Dec 31, 2014 0.32%
Sep 30, 2014 21.50%
Jun 30, 2014 -2.00%
Mar 31, 2014 -32.23%
Dec 31, 2013 -17.08%
Sep 30, 2013 27.76%
Jun 30, 2013 -72.12%